![Polly Murphy](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Polly Murphy
Direktor/Vorstandsmitglied bei
ATEA PHARMACEUTICALS, INC.
Vermögen: 1 Mio $ am 31.07.2026
Profil
Dr. Polly A. Murphy is a Chief Business Officer at Avadel Pharmaceuticals Plc, an Independent Director at Celcuity, Inc. and an Independent Director at Atea Pharmaceuticals, Inc. She is on the Board of Directors at Celcuity, Inc. and Atea Pharmaceuticals, Inc. Dr. Murphy was previously employed as a Chief Business Officer by UroGen Pharma Ltd., a Vice President-Commercial Development by Pfizer Inc., and a Senior VP-Business & Scientific Services by The Scripps Research Institute.
She received her MBA from Nova Southeastern University, Inc. and a doctorate degree from Iowa State University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 18.06.2026 | 121.745 ( 0,15 % ) | 572 202 $ | 31.07.2026 | |
CELCUITY INC. 0,01 % | 10.06.2026 | 5.000 ( 0,01 % ) | 431 900 $ | 31.07.2026 |
Aktive Positionen von Polly Murphy
| Unternehmen | Position | Beginn |
|---|---|---|
| ATEA PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 01.08.2020 |
| CELCUITY INC. | Direktor/Vorstandsmitglied | 12.09.2022 |
| AVADEL PHARMACEUTICALS PLC | Corporate Officer/Principal | 01.05.2024 |
Ehemalige bekannte Positionen von Polly Murphy
| Unternehmen | Position | Ende |
|---|---|---|
| UROGEN PHARMA LTD. | Corporate Officer/Principal | 01.05.2024 |
| PFIZER INC. | Corporate Officer/Principal | 01.08.2020 |
The Scripps Research Institute
 The Scripps Research Institute Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01.08.2008 |
Ausbildung von Polly Murphy
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
98
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Atea Pharmaceuticals, Inc.
 Atea Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes antiviral therapeutics | Health Technology |
The Scripps Research Institute
The Scripps Research Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Iowa State University
 Iowa State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nova Southeastern University, Inc.
 Nova Southeastern University, Inc. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UroGen Pharma Ltd.
 UroGen Pharma Ltd. BiotechnologyHealth Technology Develops therapies for urological pathologies | Health Technology |
Celcuity, Inc.
 Celcuity, Inc. Medical SpecialtiesHealth Technology Operates as a biotechnology company develops novel diagnostic tests | Health Technology |
Avadel Pharmaceuticals Plc
 Avadel Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
